Coloplast A/S (CPH:COLO.B)
Denmark · Delayed Price · Currency is DKK 431.10
+8.20 (1.94%)
Aug 18, 2026, 9:59 AM CET
Coloplast Market Cap
Coloplast has a market cap or net worth of 95.22 billion as of August 17, 2026. Its market cap has decreased by -29.77% in one year.
Market Cap
95.22B
Enterprise Value
118.38B
Revenue
28.44B
Ranking
n/a
PE Ratio
45.27
Stock Price
431.10
ChartMarket Cap Chart
Since November 17, 1997, Coloplast's market cap has increased from 5.88B to 95.22B, an increase of 1,519.44%. That is a compound annual growth rate of 10.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 96.44B | -21.68% |
| Dec 30, 2025 | 123.14B | -30.43% |
| Dec 30, 2024 | 177.00B | 2.05% |
| Dec 29, 2023 | 173.44B | 0.54% |
| Dec 30, 2022 | 172.51B | -29.57% |
| Dec 30, 2021 | 244.93B | 23.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 121.01B |
| Demant | 62.72B |
| ALK-Abelló | 48.43B |
| H. Lundbeck | 40.85B |
| Zealand Pharma | 22.27B |
| Ambu A/S | 20.20B |
| GN Store Nord | 14.89B |